Key facts
- This page summarizes Susan Eylward's Form 4 filing for Imunon, Inc. (IMNN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2026, 16:17.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Sale
Additional SEC filing notes
Footnote F1
Stock granted in lieu of cash for portion of base salary
Footnote F2
Reflects a weighted average sale price of $1.6303 per share, at prices ranging from $1.61 to $1.655 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.